Repare Therapeutics Inc.
NASDAQ: RPTX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Steve Forte
- Employees
- 129
- Headquarters
- Montreal, Canada
- IPO year
- 2020
- Market cap
- $114.2M
- Website
- https://www.reparerx.com
Loading RPTX…
Loading profile data…Frequently asked questions about RPTX
What does Repare Therapeutics Inc. (RPTX) do?
Repare Therapeutics Inc. is a precision oncology biopharmaceutical company in the clinical stage, focused on discovering and developing innovative therapies. Operating across Canada and the United States, the company leverages a synthetic lethality approach to identify new treatments. Central to their efforts is the proprietary, genome-wide, and...
Where does RPTX trade?
Repare Therapeutics Inc. (RPTX) trades on the NASDAQ Global Select.
What sector is RPTX in?
Repare Therapeutics Inc. (RPTX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Repare Therapeutics Inc.?
Steve Forte is the chief executive officer of Repare Therapeutics Inc. (RPTX).
Where is Repare Therapeutics Inc. headquartered?
Repare Therapeutics Inc. is headquartered in Canada.
Does RPTX pay a dividend?
Repare Therapeutics Inc. (RPTX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RPTX go public?
Repare Therapeutics Inc. (RPTX) completed its initial public offering in 2020.